Literature DB >> 13459931

The nature of the hemorrhagic disorder accompanying hemolytic transfusion reactions in man.

J R KREVANS, D P JACKSON, C L CONLEY, R C HARTMANN.   

Abstract

Entities:  

Keywords:  BLOOD TRANSFUSION/complications; HEMORRHAGE

Mesh:

Year:  1957        PMID: 13459931

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  17 in total

1.  [THE THROMBOPLASTIC AND FIBRINOLYTIC ACTIVITIES OF RED BLOOD CELLS].

Authors:  W KUENZER; D HABERHAUSEN
Journal:  Klin Wochenschr       Date:  1964-02-15

2.  STROMA S PROTEIN RELATED TO THE BLOOD CLOTTING MECHANISM.

Authors:  N VULPIS; G VULPIS; R GIORGINO
Journal:  Blut       Date:  1964-11

3.  Blood transfusion reactions during anaesthesia. A clinical study.

Authors:  L C JENKINS; H B GRAVES
Journal:  Can Anaesth Soc J       Date:  1961-09

4.  Thromboplastic factors in platelets and red blood cells: observations on their chemical nature and function in vitro coagulation.

Authors:  S B TROUP; C F REED; G V MARINETTI; S N SWISHER
Journal:  J Clin Invest       Date:  1960-02       Impact factor: 14.808

5.  Severe opthalmologic complications following favism.

Authors:  C CHOREMIS; T JOANNIDES; B KYRIAKIDES
Journal:  Br J Ophthalmol       Date:  1960-06       Impact factor: 4.638

6.  The use of exchange transfusion in acute renal failure.

Authors:  R K SMILEY
Journal:  Can Med Assoc J       Date:  1958-11-01       Impact factor: 8.262

7.  Uncontrollable post-operative haemorrhage after incompatible blood transfusion.

Authors:  J M MOORE
Journal:  Br Med J       Date:  1958-11-15

8.  Defibrination Syndrome.

Authors: 
Journal:  Br Med J       Date:  1960-03-12

Review 9.  [Hemolytic uremic syndrome].

Authors:  H Wehinger; W Künzer
Journal:  Klin Wochenschr       Date:  1969-05-01

10.  Coagulation changes in baboons during acute experimental hemoglobinemia and dextran infusion.

Authors:  J I Spector; J E Lang; W H Crosby
Journal:  Am J Pathol       Date:  1975-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.